GlassScriptPhysician profile
Hassan Imad Bazzy
NPI 1821677311
$1,407.13
in general payments reported to CMS, 2019-2025
19 companies · $971 in 2025
The $971 reported for 2025 was more than what 97% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $436 · 2025: $971.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,384 · Education: $23.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,383.77 |
| Education | $23.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $250.49 | 2024-2025 | Azstarys |
| Supernus Pharmaceuticals, INC. | $222.89 | 2024-2025 | Qelbree |
| Collegium Pharmaceutical, INC. | $216.73 | 2025 | Jornay Pm |
| Ironshore Pharmaceuticals INC. | $162.50 | 2024 | |
| Tris Pharma INC | $106.39 | 2024-2025 | Dyanavel Xr |
| Lnhc, INC | $58.21 | 2025 | Zelsuvmi |
| Merck Sharp & Dohme LLC | $44.24 | 2024-2025 | Rotateq, Gardasil 9, Vaxelis |
| Photonicare INC | $39.11 | 2025 | Otosight Middle Ear Scope |
| Noven Therapeutics, LLC | $37.74 | 2025 | Xelstrym |
| Cranial Technologies, INC | $37.66 | 2024-2025 | Doc Band |
| Neos Therapeutics, LP | $37.22 | 2024 | Cotempla Xr-Odt |
| Aytu Biopharma, INC. | $34.57 | 2024-2025 | Karbinal |
| Acadia Pharmaceuticals INC | $33.93 | 2025 | Daybue |
| Biomerieux INC | $30.00 | 2025 | Biofire Spotfire Control Station |
| Otto Bock Healthcare LP | $23.36 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $20.98 | 2025 | Relexxii |
| Alk-Abello, INC | $20.02 | 2025 | Neffy |
| Seqirus USA INC | $17.69 | 2025 | Flucelvax |
| Kowa Pharmaceuticals America, INC. | $13.40 | 2024 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hassan Bazzy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.